These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 28471594)

  • 1. The Potential Role of Lyn Kinase in Systemic Lupus Erythematosus and Autoimmunity.
    Liossis SC; Konstantopoulou GM
    Isr Med Assoc J; 2016 Sep; 18(9):513-515. PubMed ID: 28471594
    [No Abstract]   [Full Text] [Related]  

  • 2. Lyn, Lupus, and (B) Lymphocytes, a Lesson on the Critical Balance of Kinase Signaling in Immunity.
    Brodie EJ; Infantino S; Low MSY; Tarlinton DM
    Front Immunol; 2018; 9():401. PubMed ID: 29545808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lyn Kinase Suppresses the Transcriptional Activity of IRF5 in the TLR-MyD88 Pathway to Restrain the Development of Autoimmunity.
    Ban T; Sato GR; Nishiyama A; Akiyama A; Takasuna M; Umehara M; Suzuki S; Ichino M; Matsunaga S; Kimura A; Kimura Y; Yanai H; Miyashita S; Kuromitsu J; Tsukahara K; Yoshimatsu K; Endo I; Yamamoto T; Hirano H; Ryo A; Taniguchi T; Tamura T
    Immunity; 2016 Aug; 45(2):319-32. PubMed ID: 27521268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered lipid raft-associated proximal signaling and translocation of CD45 tyrosine phosphatase in B lymphocytes from patients with systemic lupus erythematosus.
    Flores-Borja F; Kabouridis PS; Jury EC; Isenberg DA; Mageed RA
    Arthritis Rheum; 2007 Jan; 56(1):291-302. PubMed ID: 17195233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis and autoimmunity: complement deficiency and systemic lupus erythematosus revisited.
    Navratil JS; Ahearn JM
    Curr Rheumatol Rep; 2000 Feb; 2(1):32-8. PubMed ID: 11123037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6.
    Tsantikos E; Oracki SA; Quilici C; Anderson GP; Tarlinton DM; Hibbs ML
    J Immunol; 2010 Feb; 184(3):1348-60. PubMed ID: 20042579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmunity and lymphoproliferation: two genes are worse than one.
    Cohen PL
    Mol Interv; 2002 Nov; 2(7):427-30. PubMed ID: 14993405
    [No Abstract]   [Full Text] [Related]  

  • 8. Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus.
    Flores-Borja F; Kabouridis PS; Jury EC; Isenberg DA; Mageed RA
    Arthritis Rheum; 2005 Dec; 52(12):3955-65. PubMed ID: 16320343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymes as catalysts of autoimmunity.
    Weetman AP
    Lancet; 1994 Dec 24-31; 344(8939-8940):1716-7. PubMed ID: 7996997
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of sleep in the activity of lupus erythematosus: an overview of this possible relationship.
    Xerfan EMS; Andersen ML; Tomimori J; Tufik S; Facina AS
    Rheumatology (Oxford); 2021 Feb; 60(2):483-486. PubMed ID: 33241379
    [No Abstract]   [Full Text] [Related]  

  • 11. B-cell kinase lyn deficiency in patients with systemic lupus erythematosus.
    Liossis SN; Solomou EE; Dimopoulos MA; Panayiotidis P; Mavrikakis MM; Sfikakis PP
    J Investig Med; 2001 Mar; 49(2):157-65. PubMed ID: 11288756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of STAT6 promotes autoimmune disease and atopy on a susceptible genetic background.
    Lau M; Tsantikos E; Maxwell MJ; Tarlinton DM; Anderson GP; Hibbs ML
    J Autoimmun; 2012 Dec; 39(4):388-97. PubMed ID: 22867713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vivo destruction of antigen--a tool for probing and modulating an autoimmune response.
    Lachmann PJ
    Clin Exp Immunol; 1996 Nov; 106(2):187-9. PubMed ID: 8918561
    [No Abstract]   [Full Text] [Related]  

  • 14. Lyn deficiency in B cells from patients with systemic lupus erythematosus: comment on the article by Flores-Borja et al.
    Liossis SN; Solomou EE; Sikakis PP
    Arthritis Rheum; 2006 Jun; 54(6):2036-7; author reply 2037-8. PubMed ID: 16732577
    [No Abstract]   [Full Text] [Related]  

  • 15. Peripheral immature B cells: modulators of autoimmunity.
    Lee J; Sim JH; Kim IJ
    Int J Rheum Dis; 2015 Feb; 18(2):200-7. PubMed ID: 25292255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity.
    Baccala R; Hoebe K; Kono DH; Beutler B; Theofilopoulos AN
    Nat Med; 2007 May; 13(5):543-51. PubMed ID: 17479100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA4Ig alters the course of autoimmune disease development in Lyn-/- mice.
    Oracki SA; Tsantikos E; Quilici C; Light A; Schmidt T; Lew AM; Martin JE; Smith KG; Hibbs ML; Tarlinton DM
    J Immunol; 2010 Jan; 184(2):757-63. PubMed ID: 19966213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protective role for innate immunity in systemic lupus erythematosus.
    Carroll MC
    Nat Rev Immunol; 2004 Oct; 4(10):825-31. PubMed ID: 15459673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus.
    Cook HT; Botto M
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):330-7. PubMed ID: 16932712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity.
    Theofilopoulos AN; Koundouris S; Kono DH; Lawson BR
    Arthritis Res; 2001; 3(3):136-41. PubMed ID: 11299053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.